Navigation Links
Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin
Date:3/25/2009

TORONTO, March 25 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX:SDI), a company developing products for the treatment of sepsis, today announced that the 29th International Symposium on Intensive Care and Emergency Medicine in Brussels, Belgium from March 24-27, 2009 will feature a key scientific symposium entitled, "The Role of Endotoxin", that will include presentations from six thought leaders in the field of sepsis. Presentations will include topics such as defining the role that endotoxin plays in sepsis and organ dysfunction; using Spectral's Endotoxin Activity Assay (EAA(TM)) to determine optimum management of patients with intra-abdominal infections; and, the role of diagnosing and treating endotoxemia in patients with severe sepsis and septic shock.

"The prominence given to endotoxin at this significant international conference reflects the increased recognition within the critical care community of its role in sepsis," said Dr. Paul Walker, President and CEO of Spectral Diagnostics. "Results presented at this conference highlight the efficacy of our EAA(TM) in identifying patients most likely to benefit from anti-endotoxin therapies and the effectiveness of the Toraymyxin(TM) product to remove endotoxin and improve patient outcomes."

Spectral recently acquired the rights to Toraymyxin(TM) for the United States, where there is a significant unmet need for the approximately 100,000 patients that develop severe sepsis or septic shock each year. Additional information on the 29th International Symposium on Intensive Care and Emergency Medicine can be found at www.intensive.org.

About Spectral Diagnostics

Spectral is a leader in the battle against sepsis. Spectral's lead product is its Endotoxin Activity Assay (EAA(TM)), the only FDA cleared assay for the measurement of endotoxin. With the growing awareness for the role of endotoxemia in sepsi
'/>"/>

SOURCE Spectral Diagnostics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Spectral announces 2008 financial results
2. Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market
3. Surface plasmon resonances of metal nanoparticles in array can have narrower spectral widths
4. Spectral announces third quarter 2008 results
5. Spectral to bring anti-sepsis therapy to the U.S. market
6. Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
7. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
8. Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination
9. Spectral and Toray expand collaboration to include new geographic territories
10. Spectrals EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy
11. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., BOCARATON,Fla.,Nov.25/PRNewswire/--Formanybusine...henation,slargestandfastestgrowingnetworkofexpertp...sed bioidenticalhormones has grownthenumberof ph...6physicians -andisinprogresstoaddmorephysician-own...ear. ,, Inthepastyear ,BodyLogicMDhasopened13ne...
(Date:11/25/2009)...,Nov.25/PRNewswire-Asia/--SinovacBiotechLtd.(SVA),...odaythatitexecuted,ajointventure(JV)agreementtoest...novacDalian).TheJVwillresearch,develop,produce,and...teitsexpertise,andexperienceindevelopingandcommerc...gitslanduserights,manufacturingfacilitiesand,estab...
(Date:11/25/2009)...O,Nov.25/PRNewswire-FirstCall/--ArdeaBiosciences,I...harm.D.,presidentandchiefexecutiveofficer,willpres.... , ,Presentationdetailsareasfollows:,PiperJaffr...mber1,2009,Time:2:00p.m.EasternTime,Location:TheNe.../www.corporate-ir.net/ireye/,target=,_blank,title...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--IES(Nasdaq: IESC ),...onssystemsandservicesforthecommercial,industrialan...lbusinessgrouphasbeenawardedacontractfromManhattan...io-safetylab(BSL-4)replacementfacilityattheU.S.Arm...RIID)atFortDetrickinFrederick,Md. ,, ThenewUSAM...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
...Albert Einstein College of Medicine researchers pu...journal -, CLINTON, N.J., Sept. 25 Producing a s...tering an experimental drug from,Ikaria (an inject...lfide),showed promise in a study designed to reduc...ed in the online edition of the Proceedings of the...
...receives $500,000 ,genius award, with ,no strings ...cell biologist at,Fred Hutchinson Cancer Research ...rthur Fellowships, a "genius" award given annually...ion. Roth will receive $500,000 over,five years of... the Hutchinson Center,s Basic Sciences Division, ...
...pt. 25 Earlier today,Signalife announced that it ...3 million (three million three hundred thousand do... of new management,s initial sales campaign. In,th...hat is $5.28 million of,sales orders of our Fideli...e Company, and -- as we fulfill our existing order...
Other Biology Technology:New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces 2New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces 3Basic Scientist Mark Roth Wins MacArthur Fellowship 2Basic Scientist Mark Roth Wins MacArthur Fellowship 3Signalife Receives Another $3.3 Million Sales Orders 2
(Date:11/24/2009)...ors to understanding how sounds associated with Na...al or if they hear it at all. , The same type o...uses to detect flaws in the space shuttle,s behemo...o peek inside the giant head of a whale. The scans... of a whale,s hearing anatomy using a breakthrough...
(Date:11/24/2009)...arkable class of ring-shaped protein motors has be...eley National Laboratory (Berkeley Lab) using a st... the Advanced Light Source (ALS). These protein mo...lication, and are vital to the survival of all bio...as the human papillomavirus, which has been linked...
(Date:11/24/2009)...ng held secrets of the earth,s history locked in i...very little information on the environments that h...of years. Now, a team of researchers from nine ins...tune of $10 million dollars by the National Scienc...gs literally. These scientists will drill through...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2Research Finds New Crop of Breast Cancer Genes 47543 1Research Finds New Crop of Breast Cancer Genes 47543 2New Study Documents High Prevalence of Serious Mental Illnesses Among Nations Jail Populations 47540 1New Study Documents High Prevalence of Serious Mental Illnesses Among Nations Jail Populations 47540 2Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 1Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 2Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 3Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 4Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 5
...anish . , A scientific group of the Universitie...nd Nakai (China), among others, have deciphered fo...ase papaya (Carica papaya), according to the cover...ure . One of the researchers is a scientist assign...rtment of Genetics of the University of Granada...
... Caramellino, two doctoral students in NJITs grad...ed recognition at a student poster event organized... manufacture nano- and micro-sized drug particles....ty for Pharmaceutical Engineering was the sponsor....has recognized that new technologies and methods m...
...Business Assessment Group will fund four faculty r...ified these one-year projects from a number of exc...tation earlier this spring. Funding for the progr...al Property Management, and is generated by royalt...rojects show a significant probability of having c...
Other Biology News:Scientists decipher fruit tree genome for the first time 2Scientists decipher fruit tree genome for the first time 3NJIT doctoral students receive recognition at poster competition 2OSU technologies funded for development 2OSU technologies funded for development 3
Phosphate Colorimetric Assay Kit from BioAssay Systems
EnzChek cellulase substrate *blue fluorescent, 339/452 from Invitrogen
... Ladder is suitable for sizing single-stranded RNA...dehyde agarose gels. The ladder consists of nine b...0 kb) to simplify size estimation. The 1.5 kb band...y orientation and identification of RNA bands on t...
CpGenome™ Universal DNA Modification Kit from Upstate
Biology Products: